6.5.1999 Official Journal of the European Communities L 118/23 COMMISSION REGULATION (EC) No 953/1999 of 5 May 1999 amending Annexes II and III of Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin (Text with EEA relevance) THE COMMISSION OF THE EUROPEAN COMMUNITIES, maximum residue limits should therefore also always be established for muscle or fat tissues; Having regard to the Treaty establishing the European (5)  Whereas, in the case of veterinary medicinal pro- Community, ducts intended for use in laying birds, lactating animals or honey bees, maximum residue limits must also be established for eggs, milk or honey; Having regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for (6)  Whereas parconazole should be inserted into the establishment of maximum residue limits of veter- Annex II to Regulation (EEC) No 2377/90; inary medicinal products in foodstuffs of animal origin (*), as last amended by Commission Regulation (EC) No 804/ (7)  Whereas, in order to allow for the completion of 1999 (?) and in particular Articles 6, 7 and 8 thereof, scientific studies, imidocarb, carazolol, pirlimycin, danofloxacin, josamycin and bacitracin should be inserted into Annex III to Regulation (EEC) No (1)  Whereas, in accordance with Regulation (EEC) No 2377/90; 2377/90, maximum residue limits must be estab- lished progressively for all pharmacologically active (8)  Whereas a period of 60 days should be allowed substances which are used within the Community before the entry into force of this Regulation in in veterinary medicinal products intended for order to allow Member States to make any adjust- administration to food-producing animals; ment which may be necessary to the authorisations to place the veterinary medicinal products concerned on the market which have been granted ()  Whereas maximum residue limits should be estab- in accordance with Council ~Directive 81/ lished only after the examination within the 851/BEC (), as last amended by DQirpctive 9%/ Committee for Veterinary Medicinal Products of all 40/EEC (') to take account of the provisions of this the relevant information concerning the safety of Regulation; residues of the substance concerned for the consumer of foodstuffs of animal origin and the ) Whereas the measures provided for in this Regula- impact of residues on the industrial processing of tion are in accordance with the opinion of the foodstuffs; Standing Committee on Veterinary Medicinal Products, (3)  Whereas, in establishing maximum residue limits for residues of veterinary medicinal products in foodstuffs of animal origin, it is necessary to specify HAS ADOPTED THE FOLLOWING REGULATION the animal species in which residues may be present, the levels which may be present in each of the relevant meat tissues obtained from the treated animal (target tissue) and the nature of the residue which is relevant for the monitoring of residues (marker residue); Article 1 Annexes II and III of Regulation (EEC) No 2377/90 are hereby amended as set out in the Annex hereto. (40  Whereas, for the control of residues, as provided for in appropriate Community legislation, maximum Article 2 residue limits should usually be established for the target tissues of liver or kidney; whereas, however, This Regulation shall enter into force on the 60th day the liver and kidney are frequently removed from following its publication in the Official Journal of the carcasses moving in international trade, and European Communities. () OJ L 224, 18.8.1990, p. 1. @) OJ L 317, 6.11.1981, p. 1. OJ L 102, 17.4.1999, p. 58. () OJ L 214, 24.8.1993, p. 31.